LEUKOPLUS® contains filgrastim (a white blood cell growth factor analogue) produced by using the recombinant DNA technology. This factor stimulates the bone marrow to produce more white blood cells.
A sudden decrease in the number of white blood cells, i.e. neutropenia, weakens the body in its fight with infections.
LEUKOPLUS® treats neutropenia by stimulating the bone marrow to rapidly produce new blood cells. Furthermore, LEUKOPLUS® is also prescribed to increase new white blood cell production in support of therapies for immunosuppressive disorders such as AIDS and cancer therapies affecting the immune system.
Information on our site, physician or pharmacist can not replace the information received in consultation. Hasbiotech does not assume any legal responsibility if the information and references on our site are caused by misuse or misuse. The information on our site is intended for the target users, this information cannot be distributed or copied by third parties. Unauthorized use of trademarks and texts on our site is prohibited. All users using our site are deemed to have fully accepted this legal notice.
You can access our site after this warning if you confirm that you are a health worker (doctor, pharmacist, dentist etc.).
If you approve that you are a health worker (doctor, pharmacist, dentist, etc.), click on the button orum I accept lıy and if you do not approve, press the imi I do not accept ecz button.